| Product NDC: | 0067-2030 |
| Proprietary Name: | Excedrin |
| Non Proprietary Name: | Acetaminophen, Aspirin (NSAID), and Caffeine |
| Active Ingredient(s): | 250; 250; 65 mg/1; mg/1; mg/1 & nbsp; Acetaminophen, Aspirin (NSAID), and Caffeine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0067-2030 |
| Labeler Name: | Novartis Consumer Health, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20060927 |
| Package NDC: | 0067-2030-91 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0067-2030-91) > 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| NDC Code | 0067-2030-91 |
| Proprietary Name | Excedrin |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0067-2030-91) > 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| Product NDC | 0067-2030 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Acetaminophen, Aspirin (NSAID), and Caffeine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20060927 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Novartis Consumer Health, Inc. |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Strength Number | 250; 250; 65 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |